Greenbrook TMS NeuroHealth Centers Open in St. Louis Metro Area | Financial Buzz

Greenbrook TMS NeuroHealth Centers Open in St. Louis Metro Area

Leading provider of TMS Therapy marks Greenbrook’s expansion into Midwest Region

MCLEAN, Va., June 21, 2018 (GLOBE NEWSWIRE) — Greenbrook TMS NeuroHealth Centers, the nation’s largest and most experienced provider of Transcranial Magnetic Stimulation (TMS Therapy) to patients suffering with treatment-resistant depression, is pleased to announce that it is now providing TMS Therapy to patients in the St. Louis community.  Led by Greenbrook’s Regional Medical Director, Steven Harvey, M.D., Greenbrook TMS has centers now opened in Chesterfield, Creve Coeur and Ladue, with additional locations to open later this year.

Bill Leonard, Greenbrook’s President & CEO comments, “We welcome Dr. Steven Harvey to Greenbrook and are excited about the breadth of experience in TMS he brings as well as his shared mission of providing excellence in patient care.  Dr. Harvey will provide the clinical leadership throughout our expansion in the Midwest.”

Dr. Harvey adds, “I’ve been providing TMS since 2013, and I’m consistently impressed with its efficacy for depression when other treatments have failed.  Working with Greenbrook to expand the availability of TMS in the St. Louis area is an ideal partnership so that we can deliver this treatment option to more of the people who need it, in the community where I live.”

“TMS is a breakthrough therapy that has changed the paradigm of how we approach the treatment of depression,” said Chief Medical Officer of Greenbrook, Geoffrey Grammer, M.D.

TMS is an FDA-cleared, non-drug, non-sedating, non-invasive medical treatment for patients diagnosed with Major Depressive Disorder who are not improving with antidepressant medications or cannot tolerate their side-effects.  TMS can be used as a stand-alone treatment or in conjunction with medication. TMS uses magnetic pulses to stimulate areas of the brain known to control mood which have been identified as underactive in people diagnosed with depression. A typical treatment course is 36 sessions, administered 5 days a week for 4-6 weeks when depression is in its acute phase.

About Steven Harvey, M.D.
Dr. Harvey has extensive experience in providing TMS Therapy as a treatment modality for those suffering with treatment-resistant depression.  Board Certified in General Psychiatry, Dr. Harvey obtained his medical degree and completed his Residency in Psychiatry at Washington University School of Medicine in St. Louis where he currently teaches as a member of the adjunct faculty.   Recipient of the Sandoz Award for research, Dr. Harvey is first author for peer-reviewed articles in publications including Biological Psychiatry and the Annals of Clinical Psychiatry.

About Greenbrook TMS
Since opening their flagship office in McLean, VA in 2011, Greenbrook has provided more than 150,000 treatments to over 4,500 patients with TMS Therapy for the treatment of depression. Greenbrook operates an expanding network of TMS treatment centers. Greenbrook currently operates over 40 centers with plans for expansion nationally over the next two years.

Contact Information
Janna Oxman, VP Marketing
Greenbrook TMS NeuroHealth Centers
301.706.9162
joxman@greenbrooktms.com

Greenbrook TMS NeuroHealth Centers
8405 Greensboro Drive, Suite 120
McLean, VA  22102
www.greenbrooktms.com

Primary Logo